The US Food and Drug
Administration has approved
Oralair Sublingual Tablets (Allergen
Pollen Extract of 5 Grasses) to
treat allergic rhinitis (hay fever)
with or without conjunctivitis (eye
inflammation) that is induced by
certain grass pollens in people aged
10 through 65 years.
This is the first sublingual allergen
extract approved in the United
States.
Helex-A’s Oralair was approved
for use in Australia in June last year
(PD 28 Jun 2013).
THE Consumers Health Forum of Australia (CHF) is seeking a voice at the table when negotiations begin for the next Community Pharmacy Agreement (CPA) following confirmation by Health Minister Greg Hunt that the Pharmaceutical Society of Australia (PSA) will also be involved (PD yesterday).
CONSIDERED one of Australia’s most urgent public health crises, opioid-related harm is the central theme in the latest issue of the Society of Hospital Pharmacists of Australia (SHPA)’s flagship organ the Journal of Pharmacy Practice and Research (JPPR).
FEDERAL Health Minister Greg Hunt has made a commitment to build into the Seventh Community Pharmacy Agreement (7CPA) “the expanded scope of practice, where pharmacy will be involved increasingly in preventive health.”